Literature DB >> 15616758

Assessment of fracture risk.

John A Kanis1, Frederik Borgstrom, Chris De Laet, Helena Johansson, Olof Johnell, Bengt Jonsson, Anders Oden, Niklas Zethraeus, Bruce Pfleger, Nikolai Khaltaev.   

Abstract

The diagnosis of osteoporosis is based on the measurement of bone mineral density (BMD). There are a number of clinical risk factors that provide information on fracture risk over and above that given by BMD. The assessment of fracture risk thus needs to be distinguished from diagnosis to take account of the independent value of the clinical risk factors. These include age, a prior fragility fracture, a parental history of hip fracture, smoking, use of systemic corticosteroids, excess alcohol intake and rheumatoid arthritis. The independent contribution of these risk factors can be integrated by the calculation of fracture probability with or without the use of BMD. Treatment can then be offered to those identified to have a fracture probability greater than an intervention threshold.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15616758     DOI: 10.1007/s00198-004-1780-5

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  49 in total

1.  The burden of osteoporotic fractures: a method for setting intervention thresholds.

Authors:  J A Kanis; A Oden; O Johnell; B Jonsson; C de Laet; A Dawson
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

2.  Apparent pre- and postmenopausal bone loss evaluated by DXA at different skeletal sites in women: the OFELY cohort.

Authors:  M E Arlot; E Sornay-Rendu; P Garnero; B Vey-Marty; P D Delmas
Journal:  J Bone Miner Res       Date:  1997-04       Impact factor: 6.741

3.  Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease.

Authors:  J A Kanis; P Delmas; P Burckhardt; C Cooper; D Torgerson
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

4.  Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis.

Authors:  J A Kanis; O Johnell; A Oden; B Jonsson; C De Laet; A Dawson
Journal:  Bone       Date:  2000-11       Impact factor: 4.398

5.  Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture.

Authors:  J A Kanis; I P Barton; O Johnell
Journal:  Osteoporos Int       Date:  2004-07-23       Impact factor: 4.507

6.  Alcohol intake as a risk factor for fracture.

Authors:  John A Kanis; Helena Johansson; Olof Johnell; Anders Oden; Chris De Laet; John A Eisman; Huibert Pols; Alan Tenenhouse
Journal:  Osteoporos Int       Date:  2004-09-29       Impact factor: 4.507

7.  Colles' fracture of the wrist as an indicator of underlying osteoporosis in postmenopausal women: a prospective study of bone mineral density and bone turnover rate.

Authors:  S A Earnshaw; S A Cawte; A Worley; D J Hosking
Journal:  Osteoporos Int       Date:  1998       Impact factor: 4.507

Review 8.  Diagnosis of osteoporosis and assessment of fracture risk.

Authors:  John A Kanis
Journal:  Lancet       Date:  2002-06-01       Impact factor: 79.321

9.  Predicting vertebral deformity using bone densitometry at various skeletal sites and calcaneus ultrasound.

Authors:  P Ross; C Huang; J Davis; K Imose; J Yates; J Vogel; R Wasnich
Journal:  Bone       Date:  1995-03       Impact factor: 4.398

10.  A family history of fracture and fracture risk: a meta-analysis.

Authors:  J A Kanis; H Johansson; A Oden; O Johnell; C De Laet; J A Eisman; E V McCloskey; D Mellstrom; L J Melton; H A P Pols; J Reeve; A J Silman; A Tenenhouse
Journal:  Bone       Date:  2004-11       Impact factor: 4.398

View more
  338 in total

1.  Self-perceived facture risk: factors underlying women's perception of risk for osteoporotic fractures: the Risk-Stratified Osteoporosis Strategy Evaluation study (ROSE).

Authors:  M J Rothmann; J Ammentorp; M Bech; J Gram; O W Rasmussen; R Barkmann; C C Glüer; A P Hermann
Journal:  Osteoporos Int       Date:  2014-11-01       Impact factor: 4.507

2.  Experience with alendronate treatment for 7 years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures.

Authors:  Jun Iwamoto; Mitsuyoshi Uzawa
Journal:  Clin Rheumatol       Date:  2014-11-01       Impact factor: 2.980

3.  Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes.

Authors:  Ann V Schwartz; Eric Vittinghoff; Douglas C Bauer; Teresa A Hillier; Elsa S Strotmeyer; Kristine E Ensrud; Meghan G Donaldson; Jane A Cauley; Tamara B Harris; Annemarie Koster; Catherine R Womack; Lisa Palermo; Dennis M Black
Journal:  JAMA       Date:  2011-06-01       Impact factor: 56.272

4.  Cost-effectiveness of different screening strategies for osteoporosis in postmenopausal women.

Authors:  Smita Nayak; Mark S Roberts; Susan L Greenspan
Journal:  Ann Intern Med       Date:  2011-12-06       Impact factor: 25.391

5.  Simulation of the behaviour of the L1 vertebra for different material properties and loading conditions.

Authors:  Ibrahim Erdem; Eeric Truumees; Marjolein C H van der Meulen
Journal:  Comput Methods Biomech Biomed Engin       Date:  2011-12-08       Impact factor: 1.763

Review 6.  Development and use of FRAX in osteoporosis.

Authors:  J A Kanis; E V McCloskey; H Johansson; A Oden; O Ström; F Borgström
Journal:  Osteoporos Int       Date:  2010-05-13       Impact factor: 4.507

Review 7.  [Diagnosis of osteoporosis in geriatric patients - possibilities and limitations].

Authors:  Peter Mikosch
Journal:  Wien Med Wochenschr       Date:  2011-09-30

8.  Prediction of hip and other osteoporotic fractures from hip geometry in a large clinical cohort.

Authors:  W D Leslie; P S Pahlavan; J F Tsang; L M Lix
Journal:  Osteoporos Int       Date:  2009-02-24       Impact factor: 4.507

Review 9.  The pathogenesis, treatment and prevention of osteoporosis in men.

Authors:  Leif Mosekilde; Peter Vestergaard; Lars Rejnmark
Journal:  Drugs       Date:  2013-01       Impact factor: 9.546

Review 10.  Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.

Authors:  Jordi Bover; Lucía Bailone; Víctor López-Báez; Silvia Benito; Paola Ciceri; Andrea Galassi; Mario Cozzolino
Journal:  J Nephrol       Date:  2017-04-21       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.